SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019248
Filing Date
2024-05-14
Accepted
2024-05-14 16:16:02
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1043859
2 ex10-6.htm EX-10.6 38248
3 ex31.htm EX-31 37375
4 ex32.htm EX-32 9744
  Complete submission text file 0001493152-24-019248.txt   6207428

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ser-20240331.xsd EX-101.SCH 44461
6 XBRL CALCULATION FILE ser-20240331_cal.xml EX-101.CAL 65351
7 XBRL DEFINITION FILE ser-20240331_def.xml EX-101.DEF 209510
8 XBRL LABEL FILE ser-20240331_lab.xml EX-101.LAB 396393
9 XBRL PRESENTATION FILE ser-20240331_pre.xml EX-101.PRE 326124
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 885159
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 24944575
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)